EFFECT OF FGF-2 AND BMP-2 ON RAT (Rattus norvegicus) BONE MARROW STEM CELLS DIFFERENTIATION
Myocardial infarction and ischemic become the leading cause of heart disease. Blood vessel occlusion can causes ischemic, and this condition can disrupt the nutrition supply to myocardial, leading to myocardial infarction. Transplantation of stem cells become a potential therapy for this disease....
Saved in:
Main Author: | |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/34929 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Myocardial infarction and ischemic become the leading cause of heart
disease. Blood vessel occlusion can causes ischemic, and this condition can
disrupt the nutrition supply to myocardial, leading to myocardial infarction.
Transplantation of stem cells become a potential therapy for this disease. Stem
cells are pluripotent cells that have the ability to differentiate into specific type of
cells. Stem cells that have been induced to differentiate can be transplanted in the
infarct area and cause tissue regeneration. Cell differentiation into specific type of
cells mostly induced by external factors, for example growth factors. In this
research, Fibroblast Growth Factor-2 (FGF-2), Bone Morphogenetic Protein-2
(BMP-2) and SU5402 were used to induce the cell differentiation into
cardiomyocyte and endothelial cells. Analysis of cell differentiation were done in
mRNA level using Reverse Transcription – Polymerase Chain Reaction (RTPCR)
and Real Time-PCR. RT-PCR was done for Cardiac Troponin-I (CTN-I)
gene and Myocyte Enhancer Factor-2c (MEF-2c) gene as cardiomyocyte marker,
and for Vascular Endothelial Growth Factor-A (VEGF-A) gene and VEGFreceptor
(VEGFR) gene as endothelial cell marker. Real Time-PCR was done for
VEGFR gene. Treatment was devided into two groups, those were group treated
for 6 days and group treated for 8 days. Each group consisted of 3 treatment
groups, namely K (control, no treatment), P1 (treated with FGF-2 and BMP-2),
and P2 (treated with FGF-2, BMP-2, and SU5402). Stem cells differentiation was
showed by the alteration of cell morphology into spindle shape. Total RNA were
isolated at the end of treatment period, that was at day 6 and day 8. RT-PCR for
CTN-I gene and MEF-2c gene showed that CTN-I and MEF-2c were not
expressed in cells, this meant that cells did not differentiate into cardiomyocyte in
all treatment. RT-PCR for VEGF-A and VEGFR gene showed that VEGF-A gene
was expressed in all treatments, whereas VEGFR gene was expressed only in P1
and P2 treatments from 8 days treatment group. Real Time-PCR analysis showed
that all samples expressed VEGFR gene. Alignment between primer sequences
and VEGFR gene sequence showed that VEGFR gene that detected in RT-PCR
was VEGFR-1, and VEGFR gene that detected in Real Time-PCR was VEGFR-3.
This result indicated that rat bone marrow stem cells differentiated into
endothelial cells. It showed that FGF-2, BMP-2, and SU5402 could induce the
differentiation of rat bone marrow stem cells into endothelial cells. |
---|